Clinical trial
VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
NCT03820947 · Medtronic Endovascular, Industry · Terminated
Key facts
| NCT number | NCT03820947 |
|---|---|
| Title | VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial |
| Official title | Global, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal™ Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early & Advanced Stage Superficial Venous Disease |
| Lead sponsor | Medtronic Endovascular, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Venous Reflux |
| Intervention type | Device, Procedure |
| Interventions | VenaSeal™ System, Endothermal Ablation (ETA), Surgical Stripping |
| Enrollment | 506 |
| Start date | Feb 5, 2020 |
| Primary completion | Jun 12, 2024 |
| Completion | Nov 10, 2025 |
| First posted | Jan 29, 2019 |
| Last update posted | Dec 30, 2025 |
| Countries | Australia, Canada, France, Germany, Italy, Netherlands, South Korea, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: